Stocks to sell

Is the era of meme-stock rallies finally over? Probably not, but we may be witnessing a last gasp as AMC Entertainment (NYSE:AMC) stock tumbles to alarming lows. As long as AMC Entertainment is willing to dilute its current shares through common stock offerings and conversions, even the faithful “Apes” should consider cutting their losses and moving

Palantir (NYSE:PLTR) is a standout in this year’s AI-driven rally, gaining nearly 150% on a year-to-date basis thanks to strong earnings and elevated expectations. The launch of ChatGPT in November 2022 boosted AI stocks, leading many companies to discuss their AI efforts on earnings calls. Palantir stock also saw a surge in its stock price after

If you’re an income investor, then you’re probably aware of the benefits of investing in real estate investment trusts, or REITs. But not all REITs are good buys. There are unfortunately several F-rated REITs to sell from which you need to steer clear. REITs are popular with income investors because they have a structure that’s

As many remember, both in their minds and pockets, Brent crude prices reached a decade-high last year, impacting oil prices globally. In 2023, global crude prices thankfully moderated in the first half. But with both Saudi Arabia and Russia extending their oil production cuts until the end of the year and U.S. oil reserve figures

Metaverse stocks emerged with a bang a couple of years ago. In fact, Mark Zuckerberg even changed the name of his social media company to Meta Platforms (NASDAQ:META), cementing the idea that the metaverse would be the destination of the future. And yet, there’s little sign of much follow-through on the concept today. So far,

Sometimes, even the most promising growth stories can have unfortunate endings. China-based electric vehicle manufacturer Nio (NYSE:NIO) has come a long way during the past several years. Yet, Nio’s recent financial and operational data don’t support a long position in NIO stock right now. Plus, Nio is embarking on a business venture that could turn out

In a battle of the overpaid CEOs, Elon Musk recently made fun of Lucid Group (NASDAQ:LCID) CEO Peter Rawlinson for hauling in $379 million in 2022. Most of that was from options and stock awards vested during the year.  As the Automotive News points out, you won’t be able to detect the superb pay from

While no participating entity in the capital markets is infallible, retail investors may nevertheless find comfort in targeting opportunities – or exiting from them as is the case here – based on unusual options activity. For this edition, we’ll be exploring stocks to sell based on the rumblings printed by the so-called smart money. To

Previously, we gave EVgo (NASDAQ:EVGO) stock a “D” grade along with a warning for prospective shareholders. Now, even as we uncover more information and developments, we still can’t enthusiastically recommend investing in EVgo. Maybe you’re intrigued with EVgo because you envision vigorous growth in the electric vehicle (EV) charging market. Your optimism is understandable, but EVgo

QuantumScape (NYSE:QS) is a speculative growth stock, but this categorization isn’t what makes QS stock a questionable investment opportunity. You know the saying: nothing ventured, nothing gained. If the odds are in your favor, taking calculated risks in early-stage stocks with a high degree of uncertainty can be a profitable strategy. The issue with this

In the dynamic world of stock trading, there’s no denying the importance of knowing which stocks billionaires are selling. Following these financial titans in their investment decisions can be invaluable in navigating the stock market’s volatility. Their access to top-tier research and wealth of experience often shape market trends, unlocking doors to potential investment avenues

U.S. equities markets have had a decent albeit volatile year thus far, as inflation, interest rates, and geopolitical tensions have, at one time or another, weighed on investor sentiment. Let’s have a look at the numbers. Towards the end of July, the S&P 500 index had reached peak annual performance, at one point returning 19.5%.

There’s been plenty of talk about a recession that hasn’t arrived. Although the recession talks have been around for a few years, you can only kick that can down the road so far before it comes full circle. The macroeconomic atmosphere is, to put it bluntly, horrible. Student loan payments will resume in September during

It has been a rough past couple of years for Tilray Brands (NASDAQ:TLRY), but more recently, things have started to look up for TLRY stock. Last month, shares in the Canada-based cannabis company began to rally again, on the heels of a well-received quarterly earnings release. Last week, shares spiked in price yet again, except

Investors seeking defensive exposure in this market may turn their attention to mining socks. These companies, involved in locating, extracting, and processing valuable minerals vital for global industries, play an essential role as a growth engine for the global economy. Without various important base metals, entire industries wouldn’t be possible. Indeed, these companies may be

Meme stocks have had an eventful summer, with many popular shares seeing sharp rallies. While enthusiasm may not be back to peak 2021 levels, interest is certainly up. Not all meme stocks are set to prosper, though. In fact, many of the worst meme stocks out there continue to have poor fundamentals and even cloudy

This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here. 2023 has been an incredible year for the stock market. The Nasdaq Composite has risen 34% so far, its best showing since 1983. The macro picture is looking bright, with inflation on the retreat

I’m no more certain than the next speculator regarding the fate of bank stocks in 2023. We’re all aware that this year has been a tough one for the sector. The bank runs a few months back were a scary sight to behold. Thankfully, the banking sector has held up, and things are normal again. However, August

Investors who’ve dipped their toe into the waters of biotech stocks know that the chances of these stocks crashing and burning is certainly higher than with most sectors. Failure is incredibly common for firms that engage in the development of pharmaceuticals. High costs and long product development timelines combine to produce spectacular failures rates, pretty